The demand for sensor wafers continued at a good level in January-June, and the
value of shipments grew 7.1 percent from the corresponding period last year. The
demand for sensor wafers is estimated to continue its steady growth during the
whole year 2013.
In January-June, the semiconductor wafer shipments declined 17.4 percent from
the strong comparison period last year. In the end of the reporting period the
semiconductor industry sales finally started to pick up, and the demand for
semiconductor wafers is estimated to clearly improve in the second half of the
The value of Other business shipments was 1.1 (7.4) million euro in January-
June. The considerable difference is due to the loss of solar crystal sales.
Sales per market area
1 Apr- 1 Apr- 1 Jan- 1 Jan- 1 Jan-
30 Jun, 2013 30 Jun, 2012 30 Jun, 2013 30 Jun, 31 Dec, 2012
North America 41% 40% 40% 38% 37%
Europe 42% 22% 39% 24% 27%
Asia 17% 38% 21% 38% 35%
During the first half of the year, the demand was strongest in North America and
Europe. The relative proportion of Asia of net sales considerably diminished in
the reporting period. This was largely due to lower sales in Other business.
Technology sales have been a considerable part of sales to Asia.
In April-June, Okmetic's operating profit amounted to 2.0 (2.5) million euro,
i.e. 11.6 (11.2) percent of net sales. Profit for the period amounted to 1.4
(2.1) million euro. Basic earnings per share was 0.08 (0.12) euro. Diluted
earnings per share was 0.08 (0.12) euro.
In January-June, Okmetic's operating profit amounted to 3.3 (4.0) million euro,
i.e. 10.0 (9.8) percent of net sales. Profit for the period amounted to 2.6
(2.8) million euro. Basic earnings per share was 0.15 (0.17) euro. Diluted
earnings per share was 0.15 (0.16) euro.
The company's financial situation is solid. In January-June, net cash flow from
operations amounted to 1.3 (1.7) million euro. The changes in working capital
tied up in operations weakened cash flow from operations by 7.0 (3.7) million
euro. The increase in working capital was mainly due to increased stock as the
company prepared for the busiest season of the year. The reimbursement of income
tax advances from 2012 improved net cash flow for the period by 1.1 million
On 30 June 2012, the company's interest-bearing liabilities amounted to 12.8
(6.0) million euro.
Okmetic announced in January that it has signed a five-year loan agreement for
10 million euro. The loan is used for the earlier announced investments and
general corporate purposes.
At the end of the reporting period, cash and cash equivalents amounted to 5.0
(6.0) million euro. On 30 June 2013, the company's cash and cash equivalents
were 7.8 million euro lower than interest-bearing liabilities (on 30 June 2012,
cash and cash equivalents were 0.1 million euro higher than interest-bearing
liabilities). The group has ensured liquidity with committed credit facilities
of 6.0 million euro. On 30 June 2013, the committed credit facilities were fully
unused. (On 30 June 2012, 3.0 million euro of the committed credit facilities
was in use.)